RJA
BNTX icon

Raymond James & Associates’s BioNTech BNTX Stock Holding History

Raymond James & Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$302K Sell
2,541
-258
-9% -$23.7K ﹤0.01% 3399
2024
Q2 		$225K Buy
2,799
+350
+14% +$32K ﹤0.01% 3539
2024
Q1 		$226K Sell
2,449
-241
-9% -$23.1K ﹤0.01% 3548
2023
Q4 		$284K Sell
2,690
-2,889
-52% -$291K ﹤0.01% 3314
2023
Q3 		$606K Buy
5,579
+298
+6% +$33K ﹤0.01% 2772
2023
Q2 		$570K Sell
5,281
-4,987
-49% -$561K ﹤0.01% 2850
2023
Q1 		$1.28M Sell
10,268
-4,001
-28% -$549K ﹤0.01% 2300
2022
Q4 		$2.14M Sell
14,269
-6,095
-30% -$938K ﹤0.01% 1949
2022
Q3 		$2.75M Sell
20,364
-2,658
-12% -$406K ﹤0.01% 1766
2022
Q2 		$3.43M Sell
23,022
-2,843
-11% -$434K ﹤0.01% 1656
2022
Q1 		$4.41M Sell
25,865
-15,019
-37% -$2.52M ﹤0.01% 1598
2021
Q4 		$10.5M Buy
40,884
+5,796
+17% +$1.59M 0.01% 1072
2021
Q3 		$9.58M Buy
35,088
+9,704
+38% +$3.08M 0.01% 1077
2021
Q2 		$5.68M Buy
25,384
+6,061
+31% +$1.14M 0.01% 1406
2021
Q1 		$2.11M Buy
19,323
+16,367
+554% +$1.74M ﹤0.01% 1972
2020
Q4 		$241K Buy
+2,956
New +$290K ﹤0.01% 3265

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James & Associates's BNTX Position: Q3 2024 in Review

Raymond James & Associates reduced its BioNTech (BNTX) stake by 9.2% in Q3 2024, selling an estimated $23.7K and leaving 2,541 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

Raymond James & Associates first reported a position in BNTX in Q4 2020 and has held it in 16 quarters since. The position peaked at $10.5M in Q4 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Raymond James & Associates held 2,541 shares of BioNTech worth $302K as of Q3 2024.
  • Raymond James & Associates sold 258 BioNTech shares in Q3 2024, an estimated $23.7K.
  • BioNTech made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3399 holding.
  • Raymond James & Associates first reported a position in BioNTech in Q4 2020 and has held it in 16 quarters since.
  • Raymond James & Associates's BioNTech position peaked at $10.5M in Q4 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.